Skip to Main content Skip to Navigation
Other publications

Indian Pharma: A Global Leader Under Pressure

Abstract : India is a global supplier of generic drugs. Its export-oriented pharmaceutical industry is extremely profitable but encounters a number of challenges, from domestic demand to human resources. The Covid-19 pandemic has brought to light its dependence on imports from China of active pharmaceutical ingredients and chemical intermediates. As the whole world discusses how to increase the resilience of supply chains, could this be an opportunity for a Europe-India cooperation? This is the theme of the last article of our new series on India’s health sector, by Christophe Jaffrelot, Senior Research Fellow at CERI-SciencesPo/CNRS, Vihang Jumle, Project Officer at TRAFFIC WWF India and Maitreyee Kishor, a Sciences Po graduate who works at Ashoka University's Centre for Writing and Communication.
Document type :
Other publications
Complete list of metadata
Contributor : Spire Sciences Po Institutional Repository Connect in order to contact the contributor
Submitted on : Tuesday, November 10, 2020 - 4:40:17 PM
Last modification on : Tuesday, January 18, 2022 - 11:42:03 AM




Christophe Jaffrelot, Vihang Jumle, Maitreyee Kishor. Indian Pharma: A Global Leader Under Pressure. 2020. ⟨hal-02998833⟩



Record views